AmirAli Talasaz sold $39M of GH
Co-Chief Executive Officer at Guardant Health, Inc.. 260,000 shares at an average of $151.20, traded Jun 26, 2026, filed Jun 30, 2026.
Score components
- +25RoleCEO
- +25Trade size$39.3M at market
- +5Share of holdings soldSold 13% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001753159-26-000014, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 26, 2026 | MOption exercise Common Stockindirect: Shares held by Talasaz and Eskandari 2017 Family Trust10b5-1 | +111,804 | $4.18 | $467k | 1,998,308 | Jun 30, 2026 |
| Jun 26, 2026 | SOpen-market sale Common Stockindirect: Shares held by Talasaz and Eskandari 2017 Family Trust10b5-1 | -64,037 | $150.49 | $9.6M | 1,934,271 | Jun 30, 2026 |
| Jun 26, 2026 | SOpen-market sale Common Stockindirect: Shares held by Talasaz and Eskandari 2017 Family Trust10b5-1 | -52,935 | $151.16 | $8.0M | 1,881,336 | Jun 30, 2026 |
| Jun 29, 2026 | MOption exercise Common Stockindirect: Shares held by Talasaz and Eskandari 2017 Family Trust10b5-1 | +143,028 | $4.18 | $598k | 2,024,364 | Jun 30, 2026 |
| Jun 29, 2026 | SOpen-market sale Common Stockindirect: Shares held by Talasaz and Eskandari 2017 Family Trust10b5-1 | -25,812 | $150.53 | $3.9M | 1,998,552 | Jun 30, 2026 |
| Jun 29, 2026 | SOpen-market sale Common Stockindirect: Shares held by Talasaz and Eskandari 2017 Family Trust10b5-1 | -70,513 | $151.47 | $11M | 1,928,039 | Jun 30, 2026 |
| Jun 29, 2026 | SOpen-market sale Common Stockindirect: Shares held by Talasaz and Eskandari 2017 Family Trust10b5-1 | -46,663 | $152.20 | $7.1M | 1,881,376 | Jun 30, 2026 |
| Jun 29, 2026 | SOpen-market sale Common Stockindirect: Shares held by Talasaz and Eskandari 2017 Family Trust10b5-1 | -40 | $153.00 | $6,120 | 1,881,336 | Jun 30, 2026 |
| Jun 26, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -111,804 | $0.00 | $0 | 172,025 | Jun 30, 2026 |
| Jun 29, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -143,028 | $0.00 | $0 | 28,997 | Jun 30, 2026 |
Related signals
Other insiders at Guardant Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | Guardant Health, Inc. | Alex M Azar II director | $145k 826 shares | -50% | |
| 55Moderate | Guardant Health, Inc. | Darya Chudova Chief Technology Officer | $1.4M 7,738 shares | -10% | |
| 65Notable | Guardant Health, Inc. | Steve E. Krognes director | $1.2M 6,674 shares | -46% | |
| 0Weak | Guardant Health, Inc. | Musa Tariq director | $20k 116 shares | -1% | |
| 50Moderate | Guardant Health, Inc. | Kumud Kalia Chief Information Officer | $632k 4,000 shares | -9% | |
| 85Strong | Guardant Health, Inc. | AmirAli Talasaz Co-Chief Executive Officer | $6.3M 37,500 shares | -50% | |
| 0Weak | Guardant Health, Inc. | Musa Tariq director | $18k 116 shares | -1% | |
| 60Notable | Guardant Health, Inc. | Terilyn J. Monroe Chief People Officer | $7.6M 46,300 shares | -67% | |
| 50Moderate | Guardant Health, Inc. | Chris Freeman Chief Commercial Officer | $11M 63,605 shares | -49% | |
| 39Weak | Guardant Health, Inc. | Medina Manuel Hidalgo director | $279k 1,700 shares | -27% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.